Olivia Wu, PhD, is the Deputy Director of the HEHTA Research Unit at the University of Glasgow, where she also leads the Evidence Synthesis Research Programme. She has a BSc (Hons) in Pharmacy, MSc in Clinical Pharmacology and PhD in Public Health and Health Economics. Olivia’s research interest in health technology assessment methodologies focuses on the areas of evidence synthesis (including systematic review and meta-analysis of aggregate and individual patient data; direct, indirect and networked evidence), risk prediction modelling and economic evaluation. She has undertaken research in a variety of clinical areas including cardiovascular disease, hematology, obstetrics and gynecology, and rheumatology. In addition to her research, Olivia serves as a member of Technology Appraisal Committee for the National Institute for Health and Care Excellence (NICE) and the Health Service and Population Health Research Committee for the Chief Scientist Office (CSO) Scotland. She is also the Health Economics Advisor to the Scottish Intercollegiate Guidelines Network (SIGN).